Lv31
234 积分 2022-02-23 加入
The role of the PPAR system in diabetic cardiovascular risk and beyond
7小时前
求助中
Inverse Agonists of Peroxisome Proliferator-Activated Receptor Gamma: Advances and Prospects in Cancer Treatment
1个月前
已完结
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models
1个月前
已完结
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
1个月前
已完结
PPAR Agonists in Primary Biliary Cholangitis
1个月前
已完结
Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective
2个月前
已完结
Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer Therapy
2个月前
已完结
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
2个月前
已完结
Accelerated In Silico Discovery of SGR-1505: A Potent MALT1 Allosteric Inhibitor for the Treatment of Mature B-Cell Malignancies
3个月前
已完结
Proteome-Wide Ligand and Target Discovery by Using Covalent Probes and Natural Products
3个月前
已完结
皖公网安备34019202002308
